Erratum to: First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model (Gene Therapy, (2022), 10.1038/s41434-022-00313-w)

Haim Werner

doi:10.1038/s41434-022-00329-2

Erratum to: First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model (Gene Therapy, (2022), 10.1038/s41434-022-00313-w)

Human Molecular Genetics Biochemistry

Research output: Contribution to journal › Comment/debate

Original language	English
Journal	Gene Therapy
DOIs	https://doi.org/10.1038/s41434-022-00329-2
State	Accepted/In press - 2022

Access to Document

10.1038/s41434-022-00329-2

Cite this

@article{83d0e1165beb43c08d8a4489b7d271cf,

title = "Erratum to: First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model (Gene Therapy, (2022), 10.1038/s41434-022-00313-w)",

author = "Haim Werner",

year = "2022",

doi = "10.1038/s41434-022-00329-2",

language = "אנגלית",

journal = "Gene Therapy",

issn = "0969-7128",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Erratum to

T2 - First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model (Gene Therapy, (2022), 10.1038/s41434-022-00313-w)

AU - Werner, Haim

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85126240247&partnerID=8YFLogxK

U2 - 10.1038/s41434-022-00329-2

DO - 10.1038/s41434-022-00329-2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 35283485

AN - SCOPUS:85126240247

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

ER -

Erratum to: First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model (Gene Therapy, (2022), 10.1038/s41434-022-00313-w)

Access to Document

Other files and links

Cite this